China could be the first country to conduct human stem cell trials
and presents a significant opportunity for Western companies who
are brave enough to use this risky destination as a place to pursue
this potentially lucrative sector...
UK firm Avecia Biotechnology has been given a £1m (€1.5m) grant to
lead a three year project to establish a faster and cheaper
bioprocessing technology for advanced tissue engineering, primarily
to develop new skin to heal burns victims.
Despite lingering ethical, legal and social concerns, the
application of stem cell research in drug discovery and development
is set to play a greater role as areas of unmet medical needs will
need to be addressed as rates of incidence...
The ReNeuron Group has announced it has completed the scale-up and
cell banking of its lead stem cell product for stroke, which gives
the Company the potential to progress this therapy without the need
to re-derive the cells from...
Stem Cell Sciences have launched the first complete, defined medium
that enables the large-scale, consistent production of mouse ES
cells. The announcement closely follows the formation of an
exclusive agreement completed last year...
British biotechnology firm Angel has won a manufacturing contract
from stem cell therapeutics expert ReNeuron Group to produce a
master cell bank for Huntington's disease, as the company's demand
for stem cells increases.
Researchers in the US have discovered a way of generating stem
cells that could avoid the use of human embryos, potentially
bypassing one of the major obstacles to the development of
therapies based on this technology.
Researchers have used new laboratorial techniques that allowed them
for the first time to derive unlimited numbers of purified
mesenchymal precursor cells from human embryonic stem cells
(HESCs). The cells can be used for regenerative...
Serologicals has continued its acquisitive streak, buying the cell
culture business Specialty Media from Sentigen Holding Corp, for
$6.5m (€4.9m) in cash. The unit will be integrated into
Serologicals' Chemicon subsidiary.
A cell culture vessel designed by Taiwanese company CESCO
Bioengineering can produce the same amount of cells in a single
500ml bottle as would be made in 20 or more conventional roller
bottles, according to the company which is introducing...